trending Market Intelligence /marketintelligence/en/news-insights/trending/ywztxOrkTQM-dduMas1eEg2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

Global Blood Therapeutics adds director


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Climate Credit Analytics: Linking climate scenarios to financial impacts


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Global Blood Therapeutics adds director

Global Blood Therapeutics Inc. appointed Dawn Svoronos to its board.

Svoronos serves on the boards of Endocyte Inc., PTC Therapeutics Inc., Theratechnologies Inc. and Xenon Pharmaceuticals Inc. Previously, she acted as director and interim chief commercial officer of Medivation Inc. In addition, she was president of Merck Canada Inc.

South San Francisco, Calif.-based Global Blood Therapeutics is a clinical-stage biopharmaceutical company developing two therapies for the potential treatment of sickle cell disease.